PALG-AML1/2016, NCT03257241 / 2017-001308-31: A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old |
|
|
| Recruiting | 3 | 582 | Europe, US | A arm (DA-90), Daunorubicin, Cytarabine, B arm (DAC), Daunorubicin, Cladribine, Cytarabine, A arm (CLAG-M), Cladribine, Cytarabine, Mitoxantrone, G-CSF, B arm (FLAG-IDA), Fludarabine, Cytarabine, Idarubicin, G-CSF | Polish Adult Leukemia Group | Acute Myeloid Leukemia | 04/22 | 12/22 | | |
